Free Float 56,82 %
Shares Float 237,71 M
Shares Outstanding 418,32 M
BGI Genomics Co., Ltd.
Share · CNE100003449 (XSHE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BGI Genomics Co., Ltd.
No Price
Closing Price XSHE 29.04.2026:
40,30 CNY
29.04.2026 07:04
Current Prices from BGI Genomics Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SHENZHEN STOCK EXCHANGE |
300676.SZ
|
CNY
|
29.04.2026 07:04
|
40,30 CNY
| 0,02 CNY
+0,05 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in BGI Genomics Co., Ltd.:
Fund | Vol. in million 0,45 | Percentage (%) 0,01 % |
Fund | Vol. in million 35,97 | Percentage (%) 0,01 % |
Fund | Vol. in million 182,11 | Percentage (%) 0,01 % |
Company Profile for BGI Genomics Co., Ltd. Share
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
Company Data
Name BGI Genomics Co., Ltd.
Company BGI Genomics Co., Ltd.
Website
https://www.bgi.com
Primary Exchange
SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
ISIN CNE100003449
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Lijian Zhao
Market Capitalization 17 Mrd.
Country China
Currency CNY
Employees 3,7 T
Address Building No.7, 518083 Shenzhen
IPO Date 2017-07-14
Dividends from 'BGI Genomics Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 04.07.2024 | 0,10 CNY |
| 07.06.2023 | 1,00 CNY |
| 06.07.2022 | 0,35 CNY |
| 07.07.2021 | 0,35 CNY |
| 07.07.2020 | 0,10 CNY |
| 13.06.2019 | 0,10 CNY |
| 28.09.2018 | 0,20 CNY |
| 11.06.2018 | 0,30 CNY |
Ticker Symbols
| Name | Symbol |
|---|---|
| SHENZHEN STOCK EXCHANGE | 300676.SZ |
More Shares
Investors who hold BGI Genomics Co., Ltd. also have the following shares in their portfolio:
